Article ID Journal Published Year Pages File Type
8243687 International Journal of Radiation Oncology*Biology*Physics 2006 8 Pages PDF
Abstract
Conclusion: Our results support that the combination of gefitinib, RT, and gemcitabine has an acceptable toxicity but with modest activity in LAPC.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer
Authors
, , , , , , , , , , , , , , , , ,